189 related articles for article (PubMed ID: 29503142)
1. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma.
Zhang S; He J; Jia Z; Yan Z; Yang J
Urol Oncol; 2018 May; 36(5):243.e9-243.e20. PubMed ID: 29503142
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-CoA Synthetase 2 Promotes Cell Migration and Invasion of Renal Cell Carcinoma by Upregulating Lysosomal-Associated Membrane Protein 1 Expression.
Yao L; Guo X; Gui Y
Cell Physiol Biochem; 2018; 45(3):984-992. PubMed ID: 29444517
[TBL] [Abstract][Full Text] [Related]
3. Acetate promotes SNAI1 expression by ACSS2-mediated histone acetylation under glucose limitation in renal cell carcinoma cell.
Yao L; Jiang L; Zhang F; Li M; Yang B; Zhang F; Guo X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458971
[TBL] [Abstract][Full Text] [Related]
4. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
5. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Sun L; Kong Y; Cao M; Zhou H; Li H; Cui Y; Fang F; Zhang W; Li J; Zhu X; Li Q; Song T; Zhang T
Cancer Sci; 2017 Jul; 108(7):1338-1346. PubMed ID: 28387999
[TBL] [Abstract][Full Text] [Related]
8. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
[TBL] [Abstract][Full Text] [Related]
9. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma
Lin H; Zeng W; Lei Y; Chen D; Nie Z
Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism.
Yoshii Y; Furukawa T; Yoshii H; Mori T; Kiyono Y; Waki A; Kobayashi M; Tsujikawa T; Kudo T; Okazawa H; Yonekura Y; Fujibayashi Y
Cancer Sci; 2009 May; 100(5):821-7. PubMed ID: 19445015
[TBL] [Abstract][Full Text] [Related]
12. [Expression of acetyl coenzyme A synthetase 2 in colorectal cancer and its biological role].
Yu T; Cui L; Liu C; Wang G; Wu T; Huang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1174-1179. PubMed ID: 29130234
[TBL] [Abstract][Full Text] [Related]
13. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET.
Yoshii Y; Waki A; Furukawa T; Kiyono Y; Mori T; Yoshii H; Kudo T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Oct; 36(7):771-7. PubMed ID: 19720289
[TBL] [Abstract][Full Text] [Related]
14. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
15. [Knockdown of ACSS2 inhibits invasion and migration of cervical cancer cells induced by nutrient stress and its mechanism].
Su Y; Ling R; Zhou Y; Chen D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):926-931. PubMed ID: 31814569
[TBL] [Abstract][Full Text] [Related]
16. Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma.
Wang YH; Huang S; Zhu L; Yang Q; Yang XM; Gu JR; Zhang ZG; Nie HZ; Li J
Biochem Biophys Res Commun; 2019 Jun; 514(3):632-638. PubMed ID: 31076106
[TBL] [Abstract][Full Text] [Related]
17. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
[TBL] [Abstract][Full Text] [Related]
18. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms.
Gu D; Ye M; Zhu G; Bai J; Chen J; Yan L; Yu P; Lu F; Hu C; Zhong Y; Liu P; He Q; Tang Q
J Transl Med; 2024 Jan; 22(1):93. PubMed ID: 38263056
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.
Campbell L; Al-Jayyoussi G; Gutteridge R; Gumbleton N; Griffiths R; Gumbleton S; Smith MW; Griffiths DF; Gumbleton M
J Transl Med; 2013 Oct; 11():255. PubMed ID: 24119769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
